Sentences with phrase «paid financial reimbursement»

Georgia law says that you are to be paid financial reimbursement because of the lost wages, suffering and pain along with medical expenses associated with a person's injury; on the other hand, to be able to obtain just what is justifiably yours, you may need a great personal injury lawyer in Dacula that has the ability, knowledge as well as assets essential to help you to obtain said financial compensation.

Our personal injury lawyer in Cobb County GA has the experience, knowledge, as well as means required to make it easier to acquire economic compensation for the professional medical expenses, loss of earnings, and suffering and pain owed to you according to Georgia law.Our personal injury lawyer in Cobb County has the experience, resources and knowledge required to assist you and your family get the payment you rightly deserve under Georgia law.Thus, if you are searching for a personal injury lawyer in Cobb County that has the skills, assets and also experience that's required that may help you get the economic reimbursement you will deserve with regard to lost pay, hospital bills and also suffering and pain that is definitely due to you in accordance with the Georgia law then you don't need to look any further.Georgia law states that you are supposed to be paid financial reimbursement because of the lost wages, suffering and pain along with professional medical costs associated with a person's injuries; on the other hand, to be able to get that which is actually your compensation you should use a great personal injury lawyer in Cobb County that possesses the ability, expertise as well as resources necessary to assist you to receive financial reimbursement for your health - related expenditures, decrease in earnings, along with suffering and pain due to you according to Georgia law.

Not exact matches

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The differences between large and small companies are notable for most of the categories that Gallup tracked, including health insurance, wellness programs, paid maternity leave, employee assistance programs, tuition reimbursement, and financial planning or coaching.

An earlier filing might have been a telltale sign about the financial problems to come: Tesla disclosed that it had begun reimbursing Mr. Musk for his use of his private plane, justifying the cost by saying, «By paying only the variable expenses of Mr. Musk's private airplane, consistent with the reimbursement policy in place, we will recognize a cost saving as compared to the customary practice for an initial public offering road show.»

The Economic Financial and Crimes Commission has denied a report claiming that the Commission has indicted all the governors of the 36 states of the Federation and the Senate President, Bukola Saraki in the ongoing investigation of the reimbursement paid to state governments by the Federal Government for excessive deduction charged to them on account of the Paris Club and other international loans.

Tuition and fees are set at a competitive rate to help stretch your district's reimbursement funds and to minimize the financial burden for individuals who are paying «out - of - pocket.»

$ 40,000 credit card debt - Turning 58 - Have good paying job - Faced recent financial challenges (medical / family assistance) over last 5 months - Have 10 credit cards (3 with high balances, $ 15,000, $ 9,000 and $ 8,000)- Late payments only to the above 3 credit card accounts (3 mos, 2 mos, 1 month)- Made recent payments to 3 credit card accounts to bring accounts to temporary favorable status - Mortgage current - Completed graduate degree but left to pay last year out of pocket when reimbursement program was greatly reduced - Consulted with debt management counselor to go on budget and work with creditors to be paid out of a single monthly payment.

In practice this means that European game developer studios have to pay more from their own financial resources before receiving reimbursement from the Commission.

Consequently, if you are searching to get a personal injury lawyer in College Park who has the knowledge, assets and working experience that is required to assist you be given the financial reimbursement you will deserve for lost pay, medical bills in addition to suffering and pain that is due to you based on the Georgia law then look any further.

Georgia law says you're owed financial compensation as a result of the lost pay, pain and suffering as well as professional medical costs associated with ones injuries; having said that, as a way to get that which is rightfully your compensation you might need a good personal injury lawyer in College Park that has the knowledge, expertise together with resources required to make it easier to obtain financial reimbursement for the healthcare expenditures, diminished salary, and pain and suffering due to you under Georgia law.

Our personal injury lawyer in Dekalb County GA has the working experience, know - how, and also strategies necessary to assist you to get economic reimbursement for the healthcare expenditures, loss in wages, as well as suffering and pain owed to you according to Georgia law.Our personal injury lawyer in Dekalb County is knowledgeable and skilled to get you and your family the compensation you are eligible for under Georgia law.And so, if you are searching for a personal injury lawyer in Dekalb County that has the skills, resources along with working experience that is needed that may help you get the financial reimbursement you will deserve pertaining to lost wages, hospital bills along with suffering and pain which is owed to you in accordance with the Georgia law then look any further.Georgia law says that you're to be paid financial compensation due to the lost wages, suffering and pain as well as medical expenses associated with a person's injury; then again, in an effort to receive what is actually your compensation you will need a very good personal injury lawyer in Dekalb County that possesses the ability, knowledge together with assets required to help you to receive financial compensation for the health - related expenditures, diminished earnings, together with pain and suffering owing to you under Georgia law.

And I also pondered what's appropriate reimbursement in pro bono cases, where clients have no financial incentive to settle because they're not paying the bill.

Reimbursement: Periodic or lump sum payment to a spouse as compensation for their contributions, economic or non-economic, to the financial resources of the spouse paying.